Key Insights

Highlights

Treatment Research

3 treatments under study, led by Shu Gan Yi Yang Capsule

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03290313Phase 4UnknownPrimary

Clinical Trial Scheme of Shu Gan yi Yang Capsule

Showing all 1 trials

Research Network

Common Treatments

  • Shu Gan Yi Yang Capsule1
  • Supportive Psychotherapy1
  • Shu Gan Yi Yang Capsule Simulation Agent1

Active Sponsors

  • Beijing Hospital of Traditional Chinese Medicine1
  • Beijing HuiLongGuan Hospital1
  • Guizhou Yi Bai Pharmaceutical Co., Ltd.1
  • Peking University Sixth Hospital1

Activity Timeline